Apis India Ltd

Apis India Ltd

BBSE:APIS
53.94
INR
-0.38
(-0.70%)
1.74EPS
33.10P/E
7.93BMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
7.41
8.61
11.12
11.82
13.51
15.63
14.68
19.74
21.11
23.76
22.81
25.15
27.01
28.48
Basic EPS, GAAP
0.66
0.62
0.93
0.75
0.87
0.77
0.24
0.46
0.58
1.33
2.36
1.84
1.84
1.74
Free Cash Flow per Basic Share
0.66
0.56
0.97
0.67
0.35
0.06
0.91
-0.43
0.65
1.14
-0.51
0.4
0.58
- -
Dividend per Share
0.01
0.01
0.01
0.01
0.01
0.01
0.01
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
1.82
2.42
3.34
4.07
4.75
5.51
5.74
6.16
7.04
8.39
10.73
12.57
14.43
14.43
Tangible Book Value per Share
1.72
2.34
3.27
4.01
4.7
5.48
5.71
6.15
7.03
8.38
10.7
12.56
14.42
14.42
Basic Weighted Avg Shares
138
138
138
138
138
138
138
138
138
138
138
138
138
137
Sales/Revenue/Turnover
1,020
1,187
1,532
1,627
1,861
2,152
2,023
2,719
2,908
3,273
3,142
3,464
3,721
3,905
Operating Margin (%)
13.43
12.46
10.35
9.31
9.06
8.09
4.4
4.8
4.42
5.42
10.05
8.95
5.23
7.96
Depreciation Expense
6
20
18
18
21
28
30
24
24
23
19
39
47
47
Net Income, GAAP
90
86
128
103
119
106
33
64
80
183
326
253
253
238
Effective Tax Rate (%)
8.67
11.89
8.46
29.46
29.4
23.27
35.57
34.22
36.3
43.44
20.39
26.39
25.34
25.35
Profit Margin (%)
8.87
7.23
8.33
6.33
6.41
4.9
1.61
2.34
2.74
5.58
10.37
7.31
6.81
6.1
Working Capital
124
173
270
383
474
517
482
639
693
689
993
1,218
1,401
1,401
LT Debt
20
14
9
12
25
26
28
126
106
82
84
70
85
85
Total Equity
250
334
459
561
655
759
790
849
969
1,155
1,478
1,732
1,988
1,988
Return on Invested Capital (%)
21.92
17.53
18.45
11.98
10.15
10.01
4.05
5.52
4.43
5.13
13.07
10.25
5.88
9.36
Return on Capital (%)
21.62
16.82
20.19
12.31
11.35
9.91
4.31
6.26
6.72
11.38
18.4
12.93
11.29
10.73
Return on Common Equity (%)
43.98
29.39
32.18
20.2
19.62
14.92
4.21
7.75
8.78
17.18
24.73
15.79
13.62
12.82

Capital Structure

INR

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
ST Debt
382
- -
582
LT Borrowings
34
- -
32
LT Finance Leases
50
- -
54
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
138
138
138
Market Capitalization
3,715
11,344
7,928

Working Capital

INR

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
Total Current Assets
2,066
- -
2,391
Cash, Cash Equivalents & STI
7
- -
6
Accounts Receivable, Net
1,140
- -
1,307
Inventories
642
- -
813
Total Current Liabilities
772
- -
990
Payables & Accruals
- -
- -
- -
ST Debt
382
- -
582
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
15.95%
18.65%
14.78%
Free Cash Flow
75.07%
-91.26%
45.19%
Net Income, GAAP
22.11%
42.09%
-0.06%
Sales/Revenue/Turnover
9.78%
6.63%
7.42%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
789
791
791
771
3,142
2025
871
804
927
902
3,464
2026
869
962
1,095
979
3,721

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.65
0.37
1.13
0.22
2.36
2025
0.38
0.49
0.38
0.59
1.84
2026
0.18
0.51
0.28
0.77
1.84

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

CEO
Amit Anand
Full Time Employees
612
Sector
Consumer non-durables
Industry
Food: major diversified
Address
18/32, East Patel Nagar New Delhi DL India 110008
IPO Date
Oct 28, 2009
Business
Apis India Ltd. (BSE: APIS) manufactures and markets a diverse portfolio of honey products, including pure honey varieties such as multifloral, acacia, lychee, ajwain, eucalyptus, mustard, and branded offerings like Apis Himalaya, Apis Vedpro Organic, and premium gift packs; it also produces honey-based health supplements, tonics, and beverages targeting health-conscious consumers in the food and nutraceutical sectors. The company operates primarily in India with distribution through modern trade, general trade, e-commerce, and exports to select international markets. Founded in 1983 and headquartered in Ludhiana, Punjab, Apis India focuses on natural sweeteners and wellness products sourced from apiaries across the country. In recent developments, the company expanded its organic product line with new certifications and launched additional health-focused variants amid growing demand for natural immunity boosters post-pandemic; it also strengthened retail partnerships with major chains and reported robust revenue growth in fiscal 2025 through enhanced e-commerce presence.